How Lumendi’s DiLumen® EZ-Glide Streamlines Colorectal Procedures
Lumendi has introduced the DiLumen® EZ-Glide, a platform designed to improve the workflow of minimally invasive colorectal surgeries. This device has already shown tangible benefits in reducing both procedure duration and overall costs, making it a practical tool for clinicians aiming to optimize patient care without sacrificing quality.
Measurable Reductions in Procedure Time and Expenses
Cutting Procedure Length by Over a Third
Peer-reviewed research reveals that DiLumen cuts total procedure times by 36.5%. This efficiency gain translates into significant economic savings—roughly $610.16 per patient. Shorter operations also mean less exposure to anesthesia and quicker recovery periods, which collectively enhance the patient experience.
Higher Success Rates in Tissue Removal
Beyond speed, DiLumen improves clinical effectiveness. The platform achieves a 97.2% en bloc resection rate, outpacing the 87% typical of traditional techniques. Removing tissue in one piece reduces the risk of recurrence and complications, suggesting that patients benefit from more thorough treatment with this technology.
Expert Evaluations Confirm Practical Benefits
Dr. Sergey V. Kantsevoy, lead author of the pivotal study, notes that DiLumen has reshaped their colorectal procedures by cutting time and improving outcomes simultaneously. Importantly, the study reported no adverse events, reinforcing the platform’s safety profile.
Perspectives from Leading Endoscopists
Other specialists have echoed these findings. Dr. Stavros Stavropoulos and Dr. Stuart Gordon highlight how DiLumen boosts procedural efficiency while maintaining safety standards. Dr. Gordon emphasizes its particular value in challenging scenarios, such as navigating redundant colons, where conventional tools often fall short.
Distinctive Features Behind DiLumen’s Performance
A standout aspect of the DiLumen system is its conduit function, which streamlines suturing during endoscopic submucosal dissection (ESD). This capability not only speeds up procedures but also enhances patient safety by supporting same-day discharge options—further reducing hospitalization costs.
Long-Term Economic Impact Beyond Initial Savings
International studies back up DiLumen’s value by showing its role in lowering recurrence rates and improving surgical success over time. These benefits suggest that investing in this platform can reduce downstream treatment expenses, making it a cost-effective choice for healthcare systems focused on sustainable outcomes.
Lumendi: Advancing Endoscopic Technology with Patient Safety in Mind
Lumendi Ltd, headquartered in Maidenhead, UK, focuses on developing endoscopic devices that improve surgical precision and patient recovery. Its U.S.-based subsidiary, Lumendi LLC in Westport, CT, furthers this mission by delivering tools that prioritize safety and cost efficiency. For more information on their products and ongoing innovations, visit their official resources.
Common Questions About DiLumen® EZ-Glide
What exactly is the DiLumen® EZ-Glide?
The DiLumen® EZ-Glide is a double balloon interventional platform engineered to enhance both safety and efficiency during colorectal endoscopic procedures.
In what ways does DiLumen reduce procedure times?
The platform’s design cuts overall procedure duration by an average of 36.5%, enabling clinicians to complete more cases within the same timeframe.
How much can hospitals save using DiLumen?
By shortening procedures and minimizing complications, DiLumen saves approximately $610.16 per patient on average, easing financial pressure on healthcare providers.
Does DiLumen improve clinical results compared to traditional methods?
Yes; it achieves a 97.2% en bloc resection rate versus the standard 87%, indicating more effective lesion removal and better patient outcomes.
Why is DiLumen particularly suited for complex colorectal cases?
Its features enhance maneuverability and safety, proving especially useful in difficult anatomical situations like redundant colons where conventional approaches may struggle.
